Cystic Fibrosis Canada announces launch of free cystic fibrosis e-learning module
September 12, 2017 (Toronto) – It’s back to school season and thanks to a new educational resource from St. Michael’s Hospital, anyone can now easily upgrade their knowledge of cystic fibrosis (CF) to better help their patients, clients or loved ones.
The CF e-learning module contains a multitude of information that provides a comprehensive overview of CF to better equip people with the tools they need to understand this complex disease. The interactive format allows users to learn at their own speed and is great for professional or personal purposes.
The e-learning module was developed by Dr. Anju Anand and Dr. Melanie Chin from the CF clinic at St. Michael’s Hospital in Toronto in response to a need for better CF teaching resources. Cystic Fibrosis Canada is grateful for this undertaking and hopes that it is widely used by those affected by CF as we work together to care, treat and find a cure for Canadians living with CF.
The e-learning module can be accessed by anyone at any time: https://students.smh.ca/course/Respirology/CF2017/story_html5.html
About cystic fibrosis
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults. It is a multi-system disease that affects mainly the lungs and the digestive system. In the lungs, where the effects are most devastating, a build-up of thick mucus causes severe respiratory problems. Mucus also builds up in the digestive tract, making it difficult to digest and absorb nutrients from food. As improved therapies have helped to address the malnutrition issues, most deaths related to cystic fibrosis are now due to lung disease. There is no cure. In Canada on average, one baby in 3,500 suffers from cystic fibrosis while in Québec, the average is one baby in 2,500.
Cystic Fibrosis Canada
Cystic Fibrosis Canada is one of the three principal charitable organizations committed to finding a cure for cystic fibrosis and is an internationally recognized leader in funding research, innovation and clinical care. Cystic Fibrosis Canada has invested more funding in life-saving CF research and care than any other non-governmental agency in Canada. Since 1960, Cystic Fibrosis Canada has invested more than $244 million in leading research, care and advocacy, resulting in one of the world’s highest survival rates for Canadians living with cystic fibrosis.
Back to Listing